Percutaneous endoscopic gastrostomy sites infected by methicillin-resistant Staphylococcus aureus: Impact on outcome

Journal of Clinical Gastroenterology

Volumn 40, Issue 4, 2006, Pages 297-300

  Mainie, Inder ^a,b   Loughrey, Anne ^a   Watson, Jennifer ^a   Tham, Tony C K ^a  

^a ULSTER HOSPITAL   (United Kingdom)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Methicillin resistant Staphylococcus aureus; Percutaneous endoscopic gastrostomy

Indexed keywords

ADULT; AGED; ARTICLE; BACTERIAL COLONIZATION; CONTROLLED STUDY; DEVICE; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORTALITY; NONHUMAN; PERCUTANEOUS ENDOSCOPIC GASTROSTOMY; PERCUTANEOUS ENDOSCOPIC GASTROSTOMY TUBE; PRIORITY JOURNAL; STAPHYLOCOCCUS INFECTION; STATISTICAL SIGNIFICANCE; SYMPTOMATOLOGY; WOUND INFECTION;

ADOLESCENT; AGED; CEREBROVASCULAR DISORDERS; CHI-SQUARE DISTRIBUTION; DEGLUTITION DISORDERS; DEMENTIA; FEMALE; GASTROSTOMY; HUMANS; LENGTH OF STAY; MALE; METHICILLIN RESISTANCE; MIDDLE AGED; RECURRENCE; RETROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; SURGICAL WOUND INFECTION;

EID: 33748188005     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mcg.0000210096.44123.b6     Document Type: Article

References (11)

1. Abuksis G, Mor M, Segal N, et al. Percutaneous endoscopic gastrostomy: high mortality rates in hospitalized patients. Am J Gastroenterol. 2000;95(1):128-132.
2. Nunley D, Berk SL. Percutaneous endoscopic gastrostomy as an unrecognized source of methicillin-resistant Staphylococcus colonisation. Am J Gastroenterol. 1992;87:58-61.
3. Improving patient care by reducing the risk of hospital acquired infection: a progress report. National Audit Office Press Notice. Report by the Comptroller and Auditor General. HC 876 2003-2004; July 14, 2004.
4. Huang SS, Platt R. Risk of methicillin-resistant Staphylococcus aureus infection after previous infection or colonization. Clin Infect Dis. 2003;36:281-285.
5. Jain NK, Larson DE, Schroeder KW, et al. Antibiotic prophylaxis for percutaneous endoscopic gastrostomy. A prospective, randomized, double-blind clinical trial. Ann Intern Med. 1987;107:824-828.
6. British Society of Gastroenterology. Antibiotic Prophylaxis in Gastrointestinal Endoscopy. Loughborough, Leicestershire: Quorn Selective Retro; 2001.
7. Chaudhary KA, Smith OJ, Cuddy PG, Clarkston WK. PEG site infections: the emergence of methicillin resistant Staphylococcus aureus as a major pathogen. Am J Gastroenterol. 2002;97:1713-1716.
8. Hull M, Beane A, Bowen J, Settle C. Methicillin-resistant Staphylococcus aureus infection of percutaneous endoscopic gastrostomy sites. Aliment Pharmacol Ther. 2001;15:1883-1888.
9. Rao GG, Osman M, Johnson L, et al. Prevention of percutaneous endoscopic gastrostomy site infections caused by methicillin-resistant Staphylococcus aureus. J Hosp Infect. 2004;58:81-83.
10. Sheehan JJ, Hill AD, Fanning NP, et al. Percutaneous endoscopic gastrostomy: 5 years of clinical experience on 238 patients. Ir Med J. 2003;96:265-267.
11. Grant MD, Rudberg MA, Brody JA. Gastrostomy placement and mortality among hospitalized Medicare beneficiaries. JAMA. 1998;279:1973-1976.